Stay updated on Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the site and removed the previous Revision: v3.4.1 along with the government funding operating-status notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T11:27:27.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide funding notice banner was added, informing users that information may not be up to date and directing to cc.nih.gov and opm.gov for updates. The page also shows a minor revision note: Revision: v3.4.1 replaces v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-04T06:53:40.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI and documentation updates: glossary now shown; labeling updated for QC criteria submission and FEAR Act data; site revision tag updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T05:45:11.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:21:06.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Locations section added listing all study sites by state (Alabama, Arizona, California, Colorado, Connecticut, Georgia, Illinois, Indiana, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, Ohio, Pennsylvania, Texas, Utah, Wisconsin) and HHS Vulnerability Disclosure removed; revision updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T10:20:53.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Minor metadata update: Revision v3.3.2 was added and v3.3.1 was removed; there are no changes to the study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:58:12.000Z thumbnail image

Stay in the know with updates to Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page.